MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery

Withdrawn

Conditions: Diastolic Dysfunction
Peripartum Cardiomyopathy

Interventions: Diagnostic Test: A clinical Transthoracic echocardiogram

First Posted Date: 2019-10-30

Last Posted Date: 2024-08-23

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT04143997

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Probiotics in Newly Diagnosed T1D

Phase 2

Active, not recruiting

Conditions: Type 1 Diabetes Mellitus
Type 1 Diabetes
Type1diabetes

Interventions: Dietary Supplement: Visbiome
Other: Placebo

First Posted Date: 2019-10-28

Last Posted Date: 2024-11-25

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 43

Registration Number: NCT04141761

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Singing and Cardiovascular Health in Older Adults

Not Applicable

Active, not recruiting

Conditions: Cardiovascular Health
Cardiovascular Diseases
Cardiovascular Risk Factor

Interventions: Other: Control Arm
Other: Singing with Guided Video
Other: Singing with Music Therapist

First Posted Date: 2019-10-10

Last Posted Date: 2024-05-06

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 65

Registration Number: NCT04121741

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Tell us Your Food Story

Withdrawn

Conditions: Breast Neoplasms

First Posted Date: 2019-10-07

Last Posted Date: 2023-04-07

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT04117438

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Phase 2

Completed

Conditions: Hematologic Malignancies

Interventions: Drug: Tildrakizumab

First Posted Date: 2019-10-02

Last Posted Date: 2024-06-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 51

Registration Number: NCT04112810

Locations: 🇺🇸
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Preemie Prep For Parents (P3): Home Antenatal Prematurity Education

Not Applicable

Completed

Conditions: Decision Making
Premature Birth
Resuscitation
Infant, Premature
Prenatal Care

Interventions: Other: ACOG links
Other: Preemie Prep for Parents (P3) Outpatient Mobile Intervention

First Posted Date: 2019-09-18

Last Posted Date: 2024-03-05

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 175

Registration Number: NCT04093492

Locations: 🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

The Prevent Anal Cancer Palpation Study

Not Applicable

Completed

Conditions: Anal Cancer

Interventions: Behavioral: Practice Self-/Companion Exams
Behavioral: Control Arm

First Posted Date: 2019-09-16

Last Posted Date: 2024-07-09

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 718

Registration Number: NCT04090060

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States

and more 1 locations

Clinical Translational Science Institute (CTSI) Brain HQ Modules vs. Active Controls for Elderly Survivors of ICU

Not Applicable

Terminated

Conditions: Neurocognitive Disorders

Interventions: Behavioral: Brain HQ Cognitive Modules

First Posted Date: 2019-09-09

Last Posted Date: 2021-05-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 1

Registration Number: NCT04081090

Locations: 🇺🇸
Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States

Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Not Applicable

Completed

Conditions: Refractory Ascites

Interventions: Procedure: Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Procedure: Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS)

First Posted Date: 2019-08-08

Last Posted Date: 2024-12-13

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 50

Registration Number: NCT04050683

Locations: 🇺🇸
Medical College of Wisconsin/Froedtert Hospital, Milwaukee, Wisconsin, United States

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

Phase 1

Suspended

Conditions: Acute Lymphoblastic Leukemia With Failed Remission
Acute Lymphoblastic Leukemia Recurrent
Acute Lymphoblastic Leukemia, in Relapse
Acute Lymphoblastic Leukemia Not Having Achieved Remission
Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, Pediatric

Interventions: Biological: CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg)
Biological: CAR-20/19-T cells (5 x 10^5 CAR-20/19-T cells/kg)
Biological: CAR-20/19-T cells (1 x10^6 CAR-20/19-T cells/kg)
Biological: CAR-20/19-T cells

First Posted Date: 2019-08-08

Last Posted Date: 2024-11-12

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 24

Registration Number: NCT04049383

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy